Ketamine

کتامین

⚠ Unverified

🧠 Nervous SystemDissociative anaesthetic (NMDA antagonist)

Market / country: 🇺🇸 USA

Ketalar (US)

🧮 Dose calculator

General anaesthesia and premedication (adjunct) · Regimen source: FDA Ketamine · 2.2

  • • Only by persons trained in anaesthesia, with airway management, oxygen and resuscitation available. FDA Ketamine · 2.1
  • • Or 1–2 mg/kg at 0.5 mg/kg/min. Maintenance: repeat one-half to the full induction dose as needed. FDA Ketamine · 2.2

Enter age and weight.

🛡️ Safety & information

Contraindications

  • ⛔ Patients in whom a significant rise in blood pressure would be a serious hazard; hypersensitivity to ketamine. FDA Ketamine · 4

Warnings

  • • Raised BP and heart rate; emergence reactions (hallucinations, dreams, delirium); respiratory depression with rapid injection; safety under 16 y not established. FDA Ketamine · 5FDA Ketamine · 8.4

Formulations

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Ketamine · 8.1

    “Risk Summary Available data on the use of ketamine in pregnant women mostly describe its use at the time of cesarean section and have not identified a drug-associated risk of adverse maternal or fetal outcomes.”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Ketamine · 8.2

    “Risk Summary Published literature describe the presence of ketamine and its metabolite in human milk.”
  • 👶 ChildrenUse with caution

    The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Ketamine · 8.4

    “Safety and effectiveness in pediatric patients below the age of 16 have not been established.”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Ketamine · 8.5

    “In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Information on this site is compiled from online websites and references. Doz accepts no responsibility for self-medication without approval from a physician and a reliable reference, or for any consequences of using this information.

Inspired by the Saphira project; part of the content is taken from it.

For suggestions, corrections, adding drugs or anything else, you can contact me on Telegram: @cenaav